Jonathan Bench in Hackernoon
I recently sat down with Harris Bricken Attorney and web3 legal expert, Jonathan Bench, for a discussion about the controversial SEC V Ripple case. (This interview has been abridged for the ease of the readers)
Noticias HB
Sabemos lo que hacemos.
No hay sustituto para la experiencia probada. Por eso los principales medios de comunicación de todo el mundo recurren tan a menudo a Harris Sliwoski en busca de nuestros conocimientos.
HB en las noticias
Dan Harris in South China Morning Post
United States-based lawyer Dan Harris, a partner at Seattle law firm Harris Sliwoski and co-author of the China Law Blog, declared that “Hong Kong is over.” He said foreign lawyers had snubbed the city in contracts that did not involve parties from China.
Fred Rocafort in the Trademark Lawyer
This case is just one of many involving the use of famous candy or snack brands on cannabis products.
Dan Harris in WDRB.com
In fact, judgments in American courts have “virtually no value in China,” attorney Dan Harris of the international law firm Harris Sliwoski wrote in a blog post last year, noting that China and the U.S. don’t have a treaty or other reciprocal accord on civil court orders.
Griffen Thorne in MJBizDaily
“This data is going to be used to support some sort of showing that there is a medical benefit,” said Griffen Thorne, a Los Angeles-based attorney at Harris Bricken.
“Everybody knows there is some medical benefit, at least for pain if for nothing else.”
But will that convince federal regulators? It’s still anyone’s guess.
“It’s hard to deduce what the federal government is doing,” Thorne noted.
Jack Scrantom in Law360
In May, Washington state signed S.B. 5367 into law, a largely unpublicized bill “concerning the regulation of products containing THC”. For Washington, this means selling CBD products containing any THC will now require licensure by the Washington State Liquor and Cannabis Board, effective July 23.
Law360 published Harris Sliwoski cannabis attorney Jack Scrantom’s legal analysis on how this bill will impact the future of Washington’s CBD industry.